5-(2- 18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET

Journal of Nuclear Medicine

Volumn 53, Issue 3, 2012, Pages 434-442

  Krämer, Stefanie D ^a   Mu, Linjing ^b   Müller, Adrienne ^a   Keller, Claudia ^a   Kuznetsova, Olga F ^a,c   Schweinsberg, Christian ^b   Franck, Dominic ^a   Müller, Cristina ^a   Ross, Tobias L ^a   Schibli, Roger ^a   Ametamey, Simon M ^a  

^a ETH Zurich   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c Institute of the Human Brain Russian Academy of Sciences   (Russian Federation)

Author keywords

LAT; PET; SLC7A; Tryptophan; Tumor imaging

Indexed keywords

5 (2 FLUOROETHOXY)TRYPTOPHAN F 18; 6 FLUORODOPA F 18; ALBUMIN; CARBIDOPA; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 5 (2 FLUOROETHOXY)TRYPTOPHAN; 5-(2-FLUOROETHOXY)TRYPTOPHAN; AMINO ACID TRANSPORTER; AROMATIC LEVO AMINO ACID DECARBOXYLASE; DIAGNOSTIC AGENT; DOPA; DRUG DERIVATIVE; ENZYME INHIBITOR; SERUM ALBUMIN; TRYPTOPHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG SYNTHESIS; DRUG TRANSPORT; DRUG UPTAKE; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; ISOTOPE TRACING; LUNG SMALL CELL CANCER; METABOLITE; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE CANCER; PSEUDOENDOCRINE PROSTATE CANCER; RADIOACTIVITY; TISSUE DISTRIBUTION; TISSUE HOMOGENATE; TUMOR XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CULTURE; DRUG ANTAGONISM; FEMALE; IMAGE PROCESSING; METABOLISM; METHODOLOGY; NEOPLASM; SCINTISCANNING; SYNTHESIS; TUMOR CELL LINE;

AMINO ACID TRANSPORT SYSTEM L; ANIMALS; AROMATIC-L-AMINO-ACID DECARBOXYLASES; CELL LINE, TUMOR; CELLS, CULTURED; DIHYDROXYPHENYLALANINE; ENZYME INHIBITORS; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SERUM ALBUMIN; TISSUE DISTRIBUTION; TRYPTOPHAN;

EID: 84858599002     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.096289     Document Type: Article

References (41)

1. Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med. 2008;49(suppl):43S-63S. (Pubitemid 351948036)
2. 18F] fluoroethyl)-L-tyrosine: uptake mechanisms and clinical applications. Nucl Med Biol. 2006;33:287-294.
3. Sundin A, Eriksson B, Bergstrom M, et al. PET in the diagnosis of neuroendocrine tumors. Ann N Y Acad Sci. 2004;1014:246-257. (Pubitemid 38594812)
4. Pearse AG. The APUD concept and hormone production. Clin Endocrinol Metab. 1980;9:211-222. (Pubitemid 10005339)
5. 18F]fluoro-3,4-dihydroxy- L-phenylalanine accumulation in neuroendocrine tumor cells. Cancer Res. 2008;68:7183-7190.
6. Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev. 2008;108:1501-1516. (Pubitemid 351796395)
7. 18F]fluoroethoxy) tryptophan as a new PET tracer. Appl Radiat Isot. 2010;68:303-308.
8. Carney DN, Gazdar AF, Bepler G, et al. Establishment and identification of small cell lung-cancer cell-lines having classic and variant features. Cancer Res. 1985;45:2913-2923. (Pubitemid 15232769)
9. Avgeris M, Koutalellis G, Fragoulis EG, Scorilas A. Expression analysis and clinical utility of L-Dopa decarboxylase (DDC) in prostate cancer. Clin Biochem. 2008;41:1140-1149.
10. 14C]cyclobutanecarboxylic acid in prostate cancer cells. Nucl Med Biol. 2012;39:109-119.
11. Miko E, Margitai Z, Czimmerer Z, et al. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5. FEBS Lett. 2011;585:1191-1196.
12. Travers MT, Gow IF, Barber MC, et al. Indoleamine 2,3-dioxygenase activity and L-tryptophan transport in human breast cancer cells. Biochim Biophys Acta. 2004;1661:106-112.
13. 18F]fluoro-L-dopa. Int J Rad Appl Instrum A. 1992;43:989-996.
14. UniProt Consortium. UniProt Web site. Available at: www.uniprot.org. Accessed January 19, 2012.
15. 2 receptors in mice using quad-HIDAC PET. J Nucl Med. 2004;45:464-470.
16. Wang Y, Seidel J, Tsui BM, et al. Performance evaluation of the GE Healthcare eXplore VISTA dual-ring small-animal PET scanner. J Nucl Med. 2006;47:1891-1900. (Pubitemid 47545013)
17. Verbeek MM, Geurtz PB, Willemsen MA, Wevers RA. Aromatic L-amino acid decarboxylase enzyme activity in deficient patients and heterozygotes. Mol Genet Metab. 2007;90:363-369. (Pubitemid 46505283)
18. Gilbert JA, Frederick LM, Ames MM. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells. Clin Cancer Res. 2000;6:4365-4372.
19. 11C] 5-hydroxy-L-tryptophan uptake and decarboxylation in carcinoid tumors by specific positioning labeling in positron emission tomography. Nucl Med Biol. 2000;27:33-41.
20. Yuwiler A, Oldendorf WH, Geller E, Braun L. Effect of albumin binding and amino acid competition on tryptophan uptake into brain. J Neurochem. 1977;28:1015-1023. (Pubitemid 8098869)
21. Jacquez JA, Sherman JH, Terris J. Temperature dependence of amino acid transport in Ehrlich ascites cells: with results which bear on the A-L distinction. Biochim Biophys Acta. 1970;203:150-166.
22. Verrey F. System L: heteromeric exchangers of large, neutral amino acids involved in directional transport. Pflugers Arch. 2003;445:529-533. (Pubitemid 36286884)
23. Stevens BR, Ross HJ, Wright EM. Multiple transport pathways for neutral amino acids in rabbit jejunal brush-border vesicles. J Membr Biol. 1982;66:213-225. (Pubitemid 12059586)
24. Kudo Y, Boyd CA. Characterisation of L-tryptophan transporters in human placenta: a comparison of brush border and basal membrane vesicles. J Physiol. 2001;531:405-416. (Pubitemid 32229666)
25. Bröer A, Wagner CA, Lang F, Broer S. The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine. Biochem J. 2000;349:787-795. (Pubitemid 30609410)
26. Pfeiffer R, Rossier G, Spindler B, et al. Amino acid transport of y+L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein- associated amino acid transporter family. EMBO J. 1999;18:49-57. (Pubitemid 29005022)
27. Kanai Y, Fukasawa Y, Cha SH, et al. Transport properties of a system y+L neutral and basic amino acid transporter: insights into the mechanisms of substrate recognition. J Biol Chem. 2000;275:20787-20793. (Pubitemid 30457670)
28. --dependent neutral and cationic amino acid transporter B(01). J Biol Chem. 1999;274:23740-23745.
29. Kirchhoff P, Dave MH, Remy C, et al. An amino acid transporter involved in gastric acid secretion. Pflugers Arch. 2006;451:738-748. (Pubitemid 43228057)
30. Taylor PM, Hundal HS, Rennie MJ. Transport of glutamine in Xenopus laevis oocytes: relationship with transport of other amino acids. J Membr Biol. 1989;112:149-157. (Pubitemid 20010749)
31. Babu E, Kanai Y, Chairoungdua A, et al. Identification of a novel system L amino acid transporter structurally distinct from heterodimeric amino acid transporters. J Biol Chem. 2003;278:43838-43845. (Pubitemid 37346012)
32. Bodoy S, Martin L, Zorzano A, et al. Identification of LAT4, a novel amino acid transporter with system L activity. J Biol Chem. 2005;280:12002- 12011. (Pubitemid 40418518)
33. 18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo. J Nucl Med. 2007;48:2063-2071.
34. Soares-da-Silva P, Parada A, Serrao P. The O-methylated derivative of L-DOPA, 3-O-methyl-L-DOPA, fails to inhibit neuronal and non-neuronal aromatic L-amino acid decarboxylase. Brain Res. 2000;863:293-297. (Pubitemid 30201613)
35. 18F] fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205-212.
36. Imai H, Kaira K, Oriuchi N, et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res. 2010;30:4819-4828.
37. Fan X, Ross DD, Arakawa H, et al. Impact of system L amino acid transporter 1 (LAT1) on proliferation of human ovarian cancer cells: a possible target for combination therapy with anti-proliferative aminopeptidase inhibitors. Biochem Pharmacol. 2010;80:811-818.
38. Lin J, Raoof DA, Thomas DG, et al. L-type amino acid transporter-1 overexpression and melphalan sensitivity in Barrett's adenocarcinoma. Neoplasia. 2004;6:74-84. (Pubitemid 38391950)
39. 18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med. 1999;40:1367-1373.
40. Blomquist L. Species differences in the accumulation of 4-iodophenylalanine in the exocrine pancreas. Comp Biochem Physiol. 1969;28:777-782.
41. 18F] fluorodopa uptake for melanogenesis in murine metastatic melanomas. J Nucl Med. 1991;32:95-101.